Comment to “Per- and poly-fluoroalkyl substances (PFAS) in hernia meshes: Weighing the evidence and implications of upcoming EU legislation”

Bernd Klosterhalfen; Konstantinos Zarras

doi:10.4103/ijawhs.ijawhs_47_24

International Journal of Abdominal Wall and Hernia Surgery ›› 2024, Vol. 7 ›› Issue (3) : 150 -153. DOI: 10.4103/ijawhs.ijawhs_47_24

Letter to the Editor

Comment to “Per- and poly-fluoroalkyl substances (PFAS) in hernia meshes: Weighing the evidence and implications of upcoming EU legislation”

Bernd Klosterhalfen ¹^,^†
, Konstantinos Zarras ²

Author information +

History +

PDF (138KB)

Cite this article

Download citation ▾

Bernd Klosterhalfen, Konstantinos Zarras. Comment to “Per- and poly-fluoroalkyl substances (PFAS) in hernia meshes: Weighing the evidence and implications of upcoming EU legislation”. International Journal of Abdominal Wall and Hernia Surgery, 2024, 7(3): 150-153 DOI:10.4103/ijawhs.ijawhs_47_24

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Organization for Economic Co-operation and Development (OECD). Reconciling Terminology of the Universe of Per- and Polyfluoroalkyl Substances: Recommendations and Practical Guidance. Paris: OECD; 2021.

[2]

Organization for Economic Co-operation and Development (OECD). Data Analysis of the Identification of Correlations between Polymer Characteristics and Potential for Health or Ecotoxicological Concern. OECD Task Force on New Chemicals Notification and Assessment, Expert Group Meeting on Polymers;2007 March; Tokyo, Japan. Paris: OECD; 2009.

[3]	BIO by Deloitte. Technical Assistance Related to the Review of REACH with Regard to the Registration Requirements on Polymers Final Report Prepared for the European Commission (DG ENV), in Collaboration with PIEP. 2015.

[4]	Korzeniowski SH, Buck RC, Newkold RM, Kassmi AE, Laganis E, Matsuoka Y, et al. A critical review of the application of polymer of low concern regulatory criteria to fluoropolymers II: Fluoroplastics and fluoroelastomers. Integr Environ Assess Manag 2023; 19: 326- 54.

[5]	Comments submitted to date on restriction report on PFAS: ECHA. Available at the website of ECHA.

[6]	Iakovlev VV, Guelcher SA, Bendavid R. Degradation of polypropylene in vivo: A microscopic analysis of meshes explanted from patients. J Biomed Mater Res B Appl Biomater 2015; 105: 237- 48.

[7]	Mary C, Marois Y, King MW, Laroche G, Douville Y, Martin L, et al. Comparison of the in vivo behavior of polyvinylidene fluoride and polypropylene sutures used in vascular surgery. ASAIO J 1998; 44: 199- 206.

[8]	Silva RA, Silva PA, Carvalho ME. Degradation studies of some polymeric biomaterials: Polypropylene (PP) and polyvinylidene difluoride (PVDF). Mater Sci Forum 2007; 539-543: 573- 6.

[9]	Cozad MJ, Grant DA, Bachman SL, Grant DN, Ramshaw BJ, Grant SA. Materials characterization of explanted polypropylene, polyethylene terephthalate, and expanded polytetrafluoroethylene composites: Spectral and thermal analysis. J Biomed Mater Res B Appl Biomater 2010; 94B: 455- 62.

[10]	Klink CD, Junge K, Binnebösel M, Alizai HP, Otto J, Neumann UP, et al. Comparison of long-term biocompability of PVDF and PP meshes. J Invest Surg 2011; 24: 292- 9.

[11]	Wang H, Klosterhalfen B, Müllen A, Otto T, Dievernich A, Jockenhövel S. Degradation resistance of PVDF mesh in vivo in comparison to PP mesh. J Mech Behav Biomed Mater 2021; 119: 104490.

[12]	Wang H, Klosterhalfen B, Klinge U, Müllen A, Jockenhoevel S. Influence of polypropylene mesh degradation on tissue inflammatory reaction. J Biomed Mater Res A 2023; 111: 1110- 9.

[13]	Costello CR, Bachman SL, Ramshaw BJ, Grant SA. Materials characterization of explanted polypropylene hernia meshes. J Biomed Mater Res B Appl Biomater 2007; 83: 44- 9.

[14]	Clavé A, Yahi H, Hammou J-C, Montanari S, Gounon P, Clavé H. Polypropylene as a reinforcement in pelvic surgery is not inert: Comparative analysis of 100 explants. Int Urogynecol J 2010; 21: 261- 70.

[15]	Smith SE, Cozad MJ, Grant DA, Ramshaw BJ, Grant SA. Materials characterization of explanted polypropylene hernia mesh: Patient factor correlation. J Biomater Appl 2016; 30: 1026- 35.

[16]	Laroche G, Marois Y, Schwarz E, Guidoin R, King MW, Pâris E, et al. Polyvinylidene fluoride monofilament sutures: Can they be used safely for long-term anastomoses in the thoracic aorta? Artif Organs 1995; 19: 1190- 9.

[17]	The HerniaSurge Group. International guidelines for groin hernia management. Hernia 2018; 22: 1- 165.

[18]	Baker JJ, Öberg S, Rosenberg J. Reoperation for recurrence is affected by type of mesh in laparoscopic ventral hernia repair: A nationwide cohort study. Ann Surg 2023; 277: 335- 42.

[19]	Dyer O. Johnson and Johnson faces lawsuit over vaginal mesh devices. BMJ 2016; 353: i3045.

[20]	Legal news: Mesh medical device news desk. Available at the website of MESHNEWSDESK.

[21]	Jain T, Tantisuwanno C, Paul A, Takmakov P, Joy A, Isayeva I, et al. Accelerated in vitro oxidative degradation testing of polypropylene surgical mesh. J Biomed Mater Res B Appl Biomater 2023; 111: 2064- 76.

[22]	Taylor D. The failure of polypropylene surgical mesh in vivo. J Mech Behav Biomed Mater 2018; 88: 370- 6.

[23]	Imel A, Malmgren T, Dadmun M, Gido S, Mays J. In vivo oxidative degradation of polypropylene pelvic mesh. Biomaterials 2015; 73: 131- 41.

[24]	Farr NTH, Roman S, Schäfer J, Quade A, Lester D, Hearnden V, et al. A novel characterisation approach to reveal the mechano-chemical effects of oxidation and dynamic distension on polypropylene surgical mesh. RSC Adv 2021; 11: 34710- 23.

[25]	Sternschuss G, Ostergard DR, Patel H. Post-implantation alterations of polypropylene in the human. J Urol 2012; 188: 27- 32.

[26]

ECHA restriction proposal: Annex XV report. Available at the website of ECHA. How to cite this article: Klosterhalfen B, Zarras K. Comment to “Per- and poly-fluoroalkyl substances (PFAS) in hernia meshes: Weighing the evidence and implications of upcoming EU legislation” Int J Abdom Wall Hernia Surg 2024; 7: 150- 3.